AADI BIOSCIENCE INC (AADI) Forecast, Price Target & Analyst Ratings

NASDAQ:AADIUS00032Q1040

Current stock price

2.05 USD
-0.05 (-2.38%)
At close:
2.06 USD
+0.01 (+0.49%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AADI BIOSCIENCE INC (AADI).

Forecast Snapshot

Consensus Price Target

Price Target
$3.06
+ 49.27% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2025
Period
Q1 / 2025
EPS Estimate
-$0.59
Revenue Estimate

ChartMill Buy Consensus

Rating
47.50%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.06
Upside
+ 49.27%
From current price of $2.05 to mean target of $3.06, Based on 8 analyst forecasts
Low
$3.03
Median
$3.06
High
$3.15

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for AADI. The average price target is 3.06 USD. This implies a price increase of 49.27% is expected in the next year compared to the current price of 2.05.

Analyst Ratings & History

Current Analyst Ratings

AADI Current Analyst RatingAADI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

AADI Historical Analyst RatingsAADI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
47.50%
AADI was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about AADI.
In the previous month the buy percentage consensus was at a similar level.
AADI was analyzed by 8 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-08-27Piper SandlerDowngrade Overweight -> Neutral
2024-08-21TD CowenDowngrade Buy -> Hold
2024-08-21HC Wainwright & Co.Reiterate Neutral
2024-05-14HC Wainwright & Co.Reiterate Neutral
2023-12-15Piper SandlerMaintains Overweight -> Overweight
2023-12-15HC Wainwright & Co.Downgrade Buy -> Neutral
2023-11-13HC Wainwright & Co.Maintains Buy -> Buy
2023-08-10HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-08HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-17HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-29HC Wainwright & Co.Maintains Buy
2022-04-11HC Wainwright & Co.Maintains Buy
2022-01-11JefferiesInitiate Buy
2021-11-24HC Wainwright & Co.Maintains Buy
2021-10-01Cowen & Co.Initiate Outperform
2021-09-14Ladenburg ThalmannInitiate Buy
2021-09-08Piper SandlerInitiate Overweight
2021-08-30HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2025
Period
Q1 / 2025
EPS Estimate
-$0.59
Revenue Estimate
Revenue Q2Q
-100.00%
EPS Q2Q
13.75%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.68%
EPS (1 Month)
0.00%
EPS (3 Months)
10.20%

Next Earnings Summary

AADI is expected to report earnings on 5/6/2025. The consensus EPS estimate for the next earnings is -0.59 USD and the consensus revenue estimate is 0 USD.
The next earnings revenue estimate has been revised upward by 0.68% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
AADI revenue by date.AADI revenue by date.
1.12M
-92.53%
15.22M
1,258.93%
24.354M
60.01%
26.418M
8.47%
14.127M
-46.53%
15.249M
7.94%
70.633M
363.20%

-100.00%
12.75M38.25M
200.00%
EBITDA
YoY % growth
AADI ebitda by date.AADI ebitda by date.
-36.95M
-486.51%
-58.8M
-59.13%
-71.764M
-22.05%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AADI ebit by date.AADI ebit by date.
-37.06M
-482.70%
-58.96M
-59.09%
-71.933M
-22.00%
-55.743M
22.51%
-24.48M
56.08%
-24.021M
1.88%
-7.382M
69.27%
-61.659M
-735.25%
-67.065M
-8.77%
-72.675M
-8.37%
-63.24M
12.98%
-33.66M
46.77%
Operating Margin
AADI operating margin by date.AADI operating margin by date.
-3,308.93%-387.39%-295.36%-211.00%-173.29%-157.53%-10.45%N/AN/AN/A-496.00%-88.00%
EPS
YoY % growth
AADI eps by date.AADI eps by date.
-4.83
-125.49%
-2.73
43.48%
-2.44
10.62%
-2.08
3.69%
-0.68
71.14%
-1.10
-62.41%
-1.11
-0.93%
1.46
231.19%
5.36
267.13%
7.55
40.95%
9.84
30.41%
8.93
-9.33%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.59
13.75%
0.47
187.83%
-0.36
22.39%
-0.36
46.72%
Revenue
Q2Q % growth

-100.00%
51M
725.38%

-100.00%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-33.252M
-70.42%
38.046M
344.14%
-11.22M
-4.13%
-9.18M
-106.90%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AADI Yearly Revenue VS EstimatesAADI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 2027 2031 2032 20M 40M 60M
AADI Yearly EPS VS EstimatesAADI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.15%
EPS Next 5 Year
33.74%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
38.79%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

AADI BIOSCIENCE INC / AADI Forecast FAQ

What is the average price target for AADI BIOSCIENCE INC (AADI) stock?

8 analysts have analysed AADI and the average price target is 3.06 USD. This implies a price increase of 49.27% is expected in the next year compared to the current price of 2.05.

What is the next earnings date for AADI stock?

AADI BIOSCIENCE INC (AADI) will report earnings on 2025-05-06, before the market open.

What are the consensus estimates for AADI stock next earnings?

The consensus EPS estimate for the next earnings of AADI BIOSCIENCE INC (AADI) is -0.59 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for AADI BIOSCIENCE INC stock?

The consensus rating for AADI BIOSCIENCE INC (AADI) is 47.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.